Efficacy of PAP Therapy on Blood Pressure

NCT02417584 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1168

Last updated 2015-04-15

No results posted yet for this study

Summary

The aim of the study was to determine the long term effects of compliance with positive airway pressure therapy on blood pressure in both hypertensive and normotensive patients with obstructive sleep apnoea hypopnoea syndrome.

Conditions

  • Obstructive Sleep Apnoea

Interventions

DEVICE

positive airway pressure (PAP)

Positive Airway Pressure (PAP) is a non-invasive machine providing air pressure f to prevent the collapse of the oropharyngeal walls and the obstruction of airflow during sleep, which occurs in obstructive sleep apnea hypopnea syndrome.

Sponsors & Collaborators

  • University of Crete

    lead OTHER

Principal Investigators

  • Sophia E Schiza, MD, PhD · University of Crete

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2011-06-30
Completion
2014-05-31

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02417584 on ClinicalTrials.gov